GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel
Clinical trial NCT04538833 · WITHDRAWN
Trial details
- NCT number
- NCT04538833
- Sponsor
- Henan Cancer Hospital
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2022-08-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.